FA
TPI

Financial Advantage’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Financial Advantage’s Portfolio TPI Stock Details TPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$1K – 249
2013
Q3 		$1K Hold
1,000
– – ﹤0.01% 211
2013
Q2 		$0 Buy
+1,000
New +$588 ﹤0.01% 227

Other funds holding TPI

PAM
Pope Asset Management Memphis, Tennessee $162M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
RIM
Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Financial Advantage's TPI Position: Q4 2013 in Review

Financial Advantage sold out of TIANYIN PHARMACEUTICAL (TPI) in Q4 2013, closing a stake of 1,000 shares — an estimated $1K sold.

Financial Advantage first reported a position in TPI in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 8 funds tracked by Wall St. Rank hold TPI as of Q4 2013.

  • Financial Advantage reported no remaining TIANYIN PHARMACEUTICAL position as of Q4 2013 after selling out during the quarter.
  • Financial Advantage sold 1,000 TIANYIN PHARMACEUTICAL shares in Q4 2013, an estimated $1K.
  • Financial Advantage first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and held it in 2 quarters.
  • Financial Advantage's TIANYIN PHARMACEUTICAL position peaked at $1K in Q3 2013.
  • 8 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q4 2013.

Based on Financial Advantage's 13F filing for Q4 2013, filed 12 Feb 2014.